The strong dollar had a negative impact on Novartis’ financial results for the first quarter offsetting strong volume growth and productivity gains. Net sales were $11.9 billion, down by 7% from a year earlier and the operating profit was $2.8 billion, down by 1%. The company reported a net income of $2.3 billion for the period, down by 6%.
